Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01269372 · ClinicalTrials.gov registry record · NA
Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon
A NA study of Colorectal Lesions, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01269372: Completed NA study of Colorectal Lesions, sponsored by Medtronic - MITG.
NCT01269372 is a NA study of Colorectal Lesions that has completed, run by Medtronic - MITG. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01269372, a NA study of Colorectal Lesions, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot, multi center study will establish the effectiveness of Given PillCam® Platform with the PillCam® Colon 2 Capsule as demonstrated by the identification of subjects with polyps, compared to standard colonoscopy. This study will also use to evaluate the administrative feasibility and data management of study design.
Primary Outcome
PillCam® Colon 2 Capsule Endoscopy (CE) compared to standard colonoscopy in detecting subjects with polyps equal to or larger than 6 mm and 10 mm as measured by Sensitivity. A positive event was defined as per optical colonoscopy polyp size measurement. Standard colonoscopy is the gold standard.
Conditions Studied
Interventions
- DEVICE PillCam Colon 2
- DEVICE Colonoscopy
Study Locations (1)
Virginia
- Gastroenterology Associates of Tidewater - Chesapeake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT01269372 record still lists
NCT01269372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Colorectal Lesions appearing as the primary indexed condition, and to 2 interventions - of which PillCam Colon 2 is the first listed.
NCT01269372 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT01269372 about?
NCT01269372 is a clinical study titled "Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon". This pilot, multi center study will establish the effectiveness of Given PillCam® Platform with the PillCam® Colon 2 Capsule as demonstrated by the identification of subjects with polyps, compared to standard colonoscopy. This study will also use to evaluate the administrative feasibility and data ...
What is the current status of trial NCT01269372?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-12. Estimated completion is 2011-07.
What conditions does trial NCT01269372 study?
This clinical trial studies the following conditions: Colorectal Lesions.
What interventions are being tested in trial NCT01269372?
The interventions under investigation include: PillCam Colon 2 (DEVICE), Colonoscopy (DEVICE).
Who is sponsoring clinical trial NCT01269372?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01269372 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01269372's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia